{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T07:41:29Z","timestamp":1753602089734},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T00:00:00Z","timestamp":1510876800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Science and Industry Endowment Fund (AU)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s10928-017-9555-8","type":"journal-article","created":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T12:21:54Z","timestamp":1510921314000},"page":"181-197","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Population in vitro\u2013in vivo pharmacokinetic model of first-pass metabolism: itraconazole and hydroxy-itraconazole"],"prefix":"10.1007","volume":"45","author":[{"given":"Ahmad Y.","family":"Abuhelwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Mudge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard N.","family":"Upton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J. R.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,17]]},"reference":[{"issue":"4","key":"9555_CR1","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1365-2125.2006.02778.x","volume":"63","author":"S Hennig","year":"2007","unstructured":"Hennig S, Waterhouse TH, Bell SC, France M, Wainwright CE, Miller H, Charles BG, Duffull SB (2007) A d-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patients. Br J Clin Pharmacol 63(4):438\u2013450. \n                        https:\/\/doi.org\/10.1111\/j.1365-2125.2006.02778.x","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"9555_CR2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.2165\/00003088-200645110-00004","volume":"45","author":"S Hennig","year":"2006","unstructured":"Hennig S, Wainwright CE, Bell SC, Miller H, Friberg LE, Charles BG (2006) Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients. Clin Pharmacokinet 45(11):1099\u20131114","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"9555_CR3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00007691-200304000-00014","volume":"25","author":"CH Koks","year":"2003","unstructured":"Koks CH, Huitema AD, Kroon ED, Chuenyam T, Sparidans RW, Lange JM, Beijnen JH (2003) Population pharmacokinetics of itraconazole in Thai HIV-1-infected persons. Ther Drug Monit 25(2):229\u2013233","journal-title":"Ther Drug Monit"},{"issue":"9","key":"9555_CR4","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.1128\/AAC.00973-15","volume":"59","author":"AY Abuhelwa","year":"2015","unstructured":"Abuhelwa AY, Foster DJ, Mudge S, Hayes D, Upton RN (2015) Population pharmacokinetic modeling of itraconazole and hydroxyitraconazole for oral SUBA-itraconazole and sporanox capsule formulations in healthy subjects in fed and fasted states. Antimicrob Agents Chemother 59(9):5681\u20135696. \n                        https:\/\/doi.org\/10.1128\/AAC.00973-15","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"9555_CR5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2165\/00003495-198937030-00003","volume":"37","author":"SM Grant","year":"1989","unstructured":"Grant SM, Clissold SP (1989) Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in superfecial and systemic mycoses. Drugs 37(3):310\u2013344","journal-title":"Drugs"},{"issue":"10","key":"9555_CR6","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1124\/dmd.104.000315","volume":"32","author":"N Isoherranen","year":"2004","unstructured":"Isoherranen N, Kunze KL, Allen KE, Nelson WL, Thummel KE (2004) Role of itraconazole metabolites in CYP3A4 inhibition. Drug Metab Dispos 32(10):1121\u20131131","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"9555_CR7","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1517\/17425255.2013.794785","volume":"9","author":"J Lestner","year":"2013","unstructured":"Lestner J, Hope WW (2013) Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections. Expert Opin Drug Metab Toxicol 9(7):911\u2013926","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"9555_CR8","unstructured":"Janssen Pharmaceuticals Inc Sporanox (itraconazole) capsules. Janssen Pharmaceuticals Inc, Beers, Belgium"},{"issue":"7","key":"9555_CR9","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1007\/s11095-016-1917-1","volume":"33","author":"AY Abuhelwa","year":"2016","unstructured":"Abuhelwa AY, Mudge S, Hayes D, Upton RN, Foster DJ (2016) Population in vitro\u2013in vivo correlation model linking gastrointestinal transit time, pH, and pharmacokinetics: itraconazole as a model drug. Pharm Res 33(7):1782\u20131794. \n                        https:\/\/doi.org\/10.1007\/s11095-016-1917-1","journal-title":"Pharm Res"},{"key":"9555_CR10","unstructured":"Beal S, Sheiner LB, Boeckmann A, Bauer RJ (2009) NONMEM user\u2019s guides, part V. (1989\u20132009), Icon Development Solutions, Ellicott City, MD"},{"key":"9555_CR11","volume-title":"R: a language and environment for statistical computing R Foundation for Statistical Computing","author":"R Core Team","year":"2014","unstructured":"R Core Team (2014) R: a language and environment for statistical computing R Foundation for Statistical Computing. Austria, Vienna"},{"key":"9555_CR12","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-98141-3","volume-title":"ggplot2: elegant graphics for data analysis","author":"H Wickham","year":"2009","unstructured":"Wickham H (2009) ggplot2: elegant graphics for data analysis. Springer, New York"},{"issue":"1","key":"9555_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v040.i01","volume":"40","author":"H Wickham","year":"2011","unstructured":"Wickham H (2011) plyr: the split-apply-combine strategy for data analysis. J Stat Softw 40(1):1\u201329","journal-title":"J Stat Softw"},{"key":"9555_CR14","unstructured":"Wickham H (2014) Scales: scale functions for graphics. CRAN.R-project.org"},{"issue":"12","key":"9555_CR15","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1128\/AAC.00630-06","volume":"50","author":"J Mouton","year":"2006","unstructured":"Mouton J, Van Peer A, De Beule K, Van Vliet A, Donnelly J, Soons P (2006) Pharmacokinetics of itraconazole and hydroxyitraconazole in healthy subjects after single and multiple doses of a novel formulation. Antimicrob Agents Chemother 50(12):4096\u20134102","journal-title":"Antimicrob Agents Chemother"},{"issue":"s1","key":"9555_CR16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1439-0507.1989.tb02296.x","volume":"32","author":"J Heykants","year":"1989","unstructured":"Heykants J, Peer A, Velde V, Rooy P, Meuldermans W, Lavrijsen K, Woestenborghs R, Cutsem J, Cauwenbergh G (1989) The clinical pharmacokinetics of itraconazole: an overview. Mycoses 32(s1):67\u201387","journal-title":"Mycoses"},{"issue":"5","key":"9555_CR17","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1208\/s12248-016-9952-8","volume":"18","author":"AY Abuhelwa","year":"2016","unstructured":"Abuhelwa AY, Foster DJ, Upton RN (2016) A quantitative review and meta-models of the variability and factors affecting oral drug absorption-part I: gastrointestinal pH. AAPS J 18(5):1309\u20131321. \n                        https:\/\/doi.org\/10.1208\/s12248-016-9952-8","journal-title":"AAPS J"},{"issue":"5","key":"9555_CR18","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1208\/s12248-016-9953-7","volume":"18","author":"AY Abuhelwa","year":"2016","unstructured":"Abuhelwa AY, Foster DJ, Upton RN (2016) A quantitative review and meta-models of the variability and factors affecting oral drug absorption-part II: gastrointestinal transit time. AAPS J 18(5):1322\u20131333. \n                        https:\/\/doi.org\/10.1208\/s12248-016-9953-7","journal-title":"AAPS J"},{"issue":"5","key":"9555_CR19","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF01061469","volume":"20","author":"JW Mandema","year":"1992","unstructured":"Mandema JW, Verotta D, Sheiner LB (1992) Building population pharmacokinetic\u2013pharmacodynamic models. I. Models for covariate effects. J Pharmacokinet Biopharm 20(5):511\u2013528","journal-title":"J Pharmacokinet Biopharm"},{"issue":"4","key":"9555_CR20","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/bja\/aeh089","volume":"92","author":"R Upton","year":"2004","unstructured":"Upton R (2004) The two-compartment recirculatory pharmacokinetic model\u2014an introduction to recirculatory pharmacokinetic concepts. Br J Anaesth 92(4):475\u2013484","journal-title":"Br J Anaesth"},{"issue":"1","key":"9555_CR21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/11317210-000000000-00000","volume":"49","author":"T Lehr","year":"2010","unstructured":"Lehr T, Staab A, Trommeshauser D, Schaefer HG, Kloft C (2010) Semi-mechanistic population pharmacokinetic drug-drug interaction modelling of a long half-life substrate and itraconazole. Clin Pharmacokinet 49(1):53\u201366","journal-title":"Clin Pharmacokinet"},{"key":"9555_CR22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/9780470191699.ch4","volume-title":"Enzyme kinetics. Drug Metabolism in drug design and development: basic concepts and practice","author":"TS Tracy","year":"2007","unstructured":"Tracy TS (2007) Enzyme kinetics. Drug Metabolism in drug design and development: basic concepts and practice. Wiley, Hoboken, pp 89\u2013112"},{"issue":"6","key":"9555_CR23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/j.1552-4604.1997.tb04332.x","volume":"37","author":"D Lange","year":"1997","unstructured":"Lange D, Pavao JH, Wu J, Klausner M (1997) Effect of a cola beverage on the bioavailability of itraconazole in the presence of H2 blockers. J Clin Pharmacol 37(6):535\u2013540","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"9555_CR24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s002280050280","volume":"52","author":"S Jaruratanasirikul","year":"1997","unstructured":"Jaruratanasirikul S, Kleepkaew A (1997) Influence of an acidic beverage (Coca-Cola) on the absorption of itraconazole. Eur J Clin Pharmacol 52(3):235\u2013237","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"9555_CR25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/clpt.2009.43","volume":"86","author":"M Bergstrand","year":"2009","unstructured":"Bergstrand M, S\u00f6derlind E, Weitschies W, Karlsson MO (2009) Mechanistic modeling of a magnetic marker monitoring study linking gastrointestinal tablet transit, in vivo drug release, and pharmacokinetics. Clin Pharmacol Ther 86(1):77\u201383","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"9555_CR26","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s11095-011-0595-2","volume":"29","author":"M Bergstrand","year":"2012","unstructured":"Bergstrand M, S\u00f6derlind E, Eriksson UG, Weitschies W, Karlsson MO (2012) A semi-mechanistic modeling strategy for characterization of regional absorption properties and prospective prediction of plasma concentrations following administration of new modified release formulations. Pharm Res 29(2):574\u2013584","journal-title":"Pharm Res"},{"issue":"3","key":"9555_CR27","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s11095-011-0594-3","volume":"29","author":"M Bergstrand","year":"2012","unstructured":"Bergstrand M, S\u00f6derlind E, Eriksson UG, Weitschies W, Karlsson MO (2012) A semi-mechanistic modeling strategy to link in vitro and in vivo drug release for modified release formulations. Pharm Res 29(3):695\u2013706","journal-title":"Pharm Res"},{"key":"9555_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-017-2113-7","author":"B Guiastrennec","year":"2017","unstructured":"Guiastrennec B, S\u00f6derlind E, Richardson S, Peric A, Bergstrand M (2017) In vitro and in vivo modeling of hydroxypropyl methylcellulose (HPMC) matrix tablet erosion under fasting and postprandial status. Pharm Res. \n                        https:\/\/doi.org\/10.1007\/s11095-017-2113-7","journal-title":"Pharm Res"},{"key":"9555_CR29","unstructured":"Mayne Pharma International Pty Ltd Lozanoc\u00ae (Itraconazole) 50\u00a0mg capsules: consumer medicine information"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10928-017-9555-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-017-9555-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-017-9555-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T13:28:13Z","timestamp":1520602093000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10928-017-9555-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,17]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["9555"],"URL":"https:\/\/doi.org\/10.1007\/s10928-017-9555-8","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,17]]}}}